QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   431.10 (+0.01%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
NYSE:RELX

Relx (RELX) Stock Price, News & Analysis

$41.28
-0.36 (-0.86%)
(As of 04/16/2024 ET)
Today's Range
$41.17
$41.47
50-Day Range
$41.03
$44.65
52-Week Range
$30.10
$44.75
Volume
1.07 million shs
Average Volume
1.12 million shs
Market Capitalization
$77.59 billion
P/E Ratio
N/A
Dividend Yield
1.70%
Price Target
N/A

Relx MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.16% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.85mentions of Relx in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
12.34%
From $1.54 to $1.73 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.02 out of 5 stars

Computer And Technology Sector

533rd out of 592 stocks

Business Services, Not Elsewhere Classified Industry

81st out of 89 stocks

RELX stock logo

About Relx Stock (NYSE:RELX)

RELX PLC, together with its subsidiaries, provides information-based analytics and decision tools for professional and business customers in North America, Europe, and internationally. It operates through four segments: Risk; Scientific, Technical & Medical; Legal; and Exhibitions. The Risk segment offers information-based analytics and decision tools that combine public and industry specific content with technology and algorithms to assist clients in evaluating and predicting risk. The Scientific, Technical & Medical segment provides information and data sets that help researchers and healthcare professionals to advance science and health outcomes. The Legal segment provides legal, regulatory, and business information and analytics that help customers in decision-making, as well as increases the productivity. The Exhibitions segment is involved in the business that combines face-to-face with data and digital tools to help customers learn about markets, source products, and complete transactions. The company was formerly known as Reed Elsevier PLC and changed its name to RELX PLC in July 2015. RELX PLC was incorporated in 1903 and is headquartered in London, the United Kingdom.

RELX Stock Price History

RELX Stock News Headlines

Relx (NYSE:RELX) Downgraded to "Hold" at StockNews.com
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
Relx (NYSE:RELX) Upgraded to "Buy" by StockNews.com
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
The hunt for good-value UK stocks
This little-known FTSE 100 stock is my top AI pick
7 Terrific Tech Stocks to Buy Instead of the Magnificent 7
See More Headlines
Receive RELX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Relx and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Employees
36,500
Year Founded
1993

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$9.91 billion
Cash Flow
$1.75 per share
Book Value
$2.27 per share

Miscellaneous

Outstanding Shares
1,879,620,000
Free Float
1,879,059,000
Market Cap
$77.74 billion
Optionable
Optionable
Beta
0.83

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Erik Engstrom M.Sc Econ (Age 61)
    M.Sc Eng., MBA, CEO & Executive Director
    Comp: $5.07M
  • Mr. Nicholas Lawrence LuffMr. Nicholas Lawrence Luff (Age 57)
    CFO & Executive Director
    Comp: $2.95M
  • Ms. Kumsal Bayazit Besson (Age 50)
    Chief Executive Officer of Scientific, Technical & Medical
  • Mr. Colin Tennant
    Head of Investor Relations
  • Mr. Henry Adam Udow (Age 66)
    Chief Legal Officer & Company Secretary
  • Mr. Paul Abrahams
    Head of Corporate Communications
  • Ms. Rosemary Thomson (Age 55)
    Chief Human Resources Officer
  • Mr. Mark Kelsey
    Chief Executive Officer of Risk
  • Ms. Jelena Sevo
    Chief Strategy Officer
  • Mr. Michael Walsh
    Chief Executive Officer of Legal

Should I Buy Relx Stock? RELX Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in Relx Plc:

  • Relx Plc operates in multiple segments, including Risk, Scientific, Technical & Medical, Legal, and Exhibitions, providing diversified revenue streams.
  • The company offers information-based analytics and decision tools that assist clients in evaluating and predicting risk, which can be crucial for informed decision-making.
  • Relx Plc serves professional and business customers globally, tapping into a broad market base for its services.
  • Recent developments in the company's technology and algorithms enhance the effectiveness of its information-based analytics, potentially leading to improved services and customer satisfaction.
  • Considering the current stock price and market trends, investing in Relx Plc may present a favorable opportunity for capital appreciation.

Cons

Investors should be bearish about investing in Relx Plc for these reasons:

  • Market competition in the information-based analytics and decision tools sector may pose challenges to Relx Plc's market share and profitability.
  • Fluctuations in global economic conditions could impact the demand for the company's services, affecting its financial performance.
  • Regulatory changes or legal challenges in the regions where Relx Plc operates may introduce uncertainties and compliance costs.
  • Exposure to currency exchange rate fluctuations due to international operations could lead to foreign exchange risks for investors.
  • Investors should carefully assess the company's financial reports and disclosures to understand any potential risks associated with investing in Relx Plc.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, April 12, 2024. Please send any questions or comments about these Relx pros and cons to contact@marketbeat.com.

RELX Stock Analysis - Frequently Asked Questions

Should I buy or sell Relx stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Relx in the last year. There are currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" RELX shares.
View RELX analyst ratings
or view top-rated stocks.

How have RELX shares performed in 2024?

Relx's stock was trading at $39.66 at the start of the year. Since then, RELX shares have increased by 4.1% and is now trading at $41.30.
View the best growth stocks for 2024 here
.

How often does Relx pay dividends? What is the dividend yield for Relx?

Relx announced a Semi-Annual dividend on Thursday, February 15th. Shareholders of record on Friday, May 3rd will be given a dividend of $0.526 per share on Tuesday, June 18th. This represents a yield of 1.7%. The ex-dividend date of this dividend is Thursday, May 2nd. This is a positive change from the stock's previous Semi-Annual dividend of $0.22.
Read our dividend analysis for RELX
.

Is Relx a good dividend stock?

Relx (NYSE:RELX) pays an annual dividend of $0.70 per share and currently has a dividend yield of 1.66%.
Read our dividend analysis for RELX.

What other stocks do shareholders of Relx own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Relx investors own include Intel (INTC), NVIDIA (NVDA), Alibaba Group (BABA), JPMorgan Chase & Co. (JPM), Pfizer (PFE), Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS), International Business Machines (IBM) and McDonald's (MCD).

Who are Relx's major shareholders?

Relx's stock is owned by a variety of institutional and retail investors. Top institutional investors include Capital Insight Partners LLC (0.00%), Park Avenue Securities LLC (0.00%), Wealth Enhancement Advisory Services LLC (0.00%), Kathmere Capital Management LLC (0.00%), Ballentine Partners LLC (0.00%) and GAMMA Investing LLC (0.00%).

How do I buy shares of Relx?

Shares of RELX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:RELX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners